NBRV logo

Nabriva Therapeutics (NBRV) Current Liabilities

Annual Current Liabilities

$27.61 M
+$5.26 M+23.57%

December 31, 2022


Summary


Performance

NBRV Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Quarterly Current Liabilities

$28.00 M
+$393.00 K+1.42%

March 31, 2023


Summary


Performance

NBRV Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NBRV Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.6%+72.1%
3 y3 years+65.9%+134.1%
5 y5 years+108.2%+145.9%

NBRV Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-19.1%at high-41.9%
5 y5-yearat high-39.7%at high-60.8%
alltimeall time-21.4%-67.7%-39.5%-68.1%

Nabriva Therapeutics Current Liabilities History

DateAnnualQuarterly
Mar 2023
-
$28.00 M(+1.4%)
Dec 2022
$27.61 M(+23.6%)
$27.61 M(+27.6%)
Sep 2022
-
$21.64 M(+11.9%)
Jun 2022
-
$19.33 M(+18.8%)
Mar 2022
-
$16.27 M(-27.2%)
Dec 2021
$22.34 M(+20.6%)
$22.34 M(+13.3%)
Sep 2021
-
$19.73 M(+2.7%)
Jun 2021
-
$19.21 M(+5.0%)
Mar 2021
-
$18.30 M(-1.2%)
Dec 2020
$18.52 M(+11.3%)
$18.52 M(+68.8%)
Sep 2020
-
$10.97 M(-0.2%)
Jun 2020
-
$11.00 M(-8.1%)
Mar 2020
-
$11.96 M(-28.1%)
Dec 2019
$16.64 M(-6.6%)
$16.64 M(+11.8%)
Sep 2019
-
$14.88 M(+5.4%)
Jun 2019
-
$14.12 M(-22.0%)
Mar 2019
-
$18.09 M(+1.6%)
DateAnnualQuarterly
Dec 2018
$17.81 M(+34.3%)
$17.81 M(+18.2%)
Sep 2018
-
$15.06 M(+33.4%)
Jun 2018
-
$11.29 M(-0.8%)
Mar 2018
-
$11.38 M(-14.1%)
Dec 2017
$13.26 M(-16.5%)
$13.26 M(-18.8%)
Sep 2017
-
$16.33 M(-2.5%)
Jun 2017
-
$16.75 M(+5.4%)
Mar 2017
-
$15.89 M(+0.1%)
Dec 2016
$15.88 M(+78.0%)
$15.88 M(+12.1%)
Sep 2016
-
$14.16 M(+18.0%)
Jun 2016
-
$12.00 M(-14.3%)
Mar 2016
-
$14.01 M(+57.1%)
Dec 2015
$8.92 M(-74.6%)
$8.92 M(-22.2%)
Sep 2015
-
$11.47 M(-17.1%)
Jun 2015
-
$13.83 M(-70.1%)
Mar 2015
-
$46.32 M(+31.9%)
Dec 2014
$35.11 M(+69.5%)
$35.11 M
Dec 2013
$20.71 M
-

FAQ

  • What is Nabriva Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual current liabilities year-on-year change?
  • What is Nabriva Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly current liabilities year-on-year change?

What is Nabriva Therapeutics annual total current liabilities?

The current annual current liabilities of NBRV is $27.61 M

What is the all time high annual current liabilities for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual total current liabilities is $35.11 M

What is Nabriva Therapeutics annual current liabilities year-on-year change?

Over the past year, NBRV annual total current liabilities has changed by +$5.26 M (+23.57%)

What is Nabriva Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of NBRV is $28.00 M

What is the all time high quarterly current liabilities for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly total current liabilities is $46.32 M

What is Nabriva Therapeutics quarterly current liabilities year-on-year change?

Over the past year, NBRV quarterly total current liabilities has changed by +$11.73 M (+72.08%)